-
Something wrong with this record ?
Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex
L. Záková, E. Kletvíková, M. Lepšík, M. Collinsová, CJ. Watson, JP. Turkenburg, J. Jiráček, AM. Brzozowski,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Phenylalanine MeSH
- Fibroblasts metabolism MeSH
- Insulin analogs & derivatives chemistry genetics metabolism MeSH
- Protein Conformation MeSH
- Crystallography, X-Ray MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Lymphocytes metabolism MeSH
- Models, Molecular MeSH
- Mutation MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Rats, Wistar MeSH
- Receptor, Insulin chemistry metabolism MeSH
- Amino Acid Substitution MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The structural characterization of the insulin-insulin receptor (IR) interaction still lacks the conformation of the crucial B21-B30 insulin region, which must be different from that in its storage forms to ensure effective receptor binding. Here, it is shown that insulin analogues modified by natural amino acids at the TyrB26 site can represent an active form of this hormone. In particular, [AsnB26]-insulin and [GlyB26]-insulin attain a B26-turn-like conformation that differs from that in all known structures of the native hormone. It also matches the receptor interface, avoiding substantial steric clashes. This indicates that insulin may attain a B26-turn-like conformation upon IR binding. Moreover, there is an unexpected, but significant, binding specificity of the AsnB26 mutant for predominantly the metabolic B isoform of the receptor. As it is correlated with the B26 bend of the B-chain of the hormone, the structures of AsnB26 analogues may provide the first structural insight into the structural origins of differential insulin signalling through insulin receptor A and B isoforms.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16021049
- 003
- CZ-PrNML
- 005
- 20160725105824.0
- 007
- ta
- 008
- 160722s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1107/S1399004714017775 $2 doi
- 024 7_
- $a 10.1107/S1399004714017775 $2 doi
- 035 __
- $a (PubMed)25286859
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Záková, Lenka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 245 10
- $a Human insulin analogues modified at the B26 site reveal a hormone conformation that is undetected in the receptor complex / $c L. Záková, E. Kletvíková, M. Lepšík, M. Collinsová, CJ. Watson, JP. Turkenburg, J. Jiráček, AM. Brzozowski,
- 520 9_
- $a The structural characterization of the insulin-insulin receptor (IR) interaction still lacks the conformation of the crucial B21-B30 insulin region, which must be different from that in its storage forms to ensure effective receptor binding. Here, it is shown that insulin analogues modified by natural amino acids at the TyrB26 site can represent an active form of this hormone. In particular, [AsnB26]-insulin and [GlyB26]-insulin attain a B26-turn-like conformation that differs from that in all known structures of the native hormone. It also matches the receptor interface, avoiding substantial steric clashes. This indicates that insulin may attain a B26-turn-like conformation upon IR binding. Moreover, there is an unexpected, but significant, binding specificity of the AsnB26 mutant for predominantly the metabolic B isoform of the receptor. As it is correlated with the B26 bend of the B-chain of the hormone, the structures of AsnB26 analogues may provide the first structural insight into the structural origins of differential insulin signalling through insulin receptor A and B isoforms.
- 650 _2
- $a substituce aminokyselin $7 D019943
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a fibroblasty $x metabolismus $7 D005347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x analogy a deriváty $x chemie $x genetika $x metabolismus $7 D007328
- 650 _2
- $a lymfocyty $x metabolismus $7 D008214
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a fenylalanin $7 D010649
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptor inzulinu $x chemie $x metabolismus $7 D011972
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kletvíková, Emília $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Collinsová, Michaela $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Watson, Christopher J $u York Structural Biology Laboratory, Department of Chemistry, The University of York, Heslington, York YO10 5DD, England.
- 700 1_
- $a Turkenburg, Johan P $u York Structural Biology Laboratory, Department of Chemistry, The University of York, Heslington, York YO10 5DD, England.
- 700 1_
- $a Jiráček, Jiří $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Brzozowski, Andrzej M $u York Structural Biology Laboratory, Department of Chemistry, The University of York, Heslington, York YO10 5DD, England.
- 773 0_
- $w MED00179510 $t Acta crystallographica. Section D, Biological crystallography. Biological crystallography $x 1399-0047 $g Roč. 70, č. Pt 10 (2014), s. 2765-74
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25286859 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160725110042 $b ABA008
- 999 __
- $a ok $b bmc $g 1155719 $s 945577
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 70 $c Pt 10 $d 2765-74 $e 20140927 $i 1399-0047 $m Acta crystallographica. Section D, Biological crystallography $n Acta Crystallogr D Biol Crystallogr $x MED00179510 $o Biological crystallography
- LZP __
- $a Pubmed-20160722